Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

<b>Background</b>: Vedolizumab trough serum levels have been associated with clinical and endoscopic response in patients with inflammatory bowel disease (IBD). A recent study demonstrated that higher trough levels before dose escalation are associated with favorable outcomes. <b>O...

Full description

Bibliographic Details
Main Authors: Asaf Levartovsky, Ido Cohen, Chaya Mushka Abitbol, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Shomron Ben-Horin, Bella Ungar
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
vedolizumab
trough levels
loss of response
subsequent therapy
therapeutic drug monitoring
Online Access:https://www.mdpi.com/2227-9059/11/6/1553

Internet

https://www.mdpi.com/2227-9059/11/6/1553

Similar Items